Advertisement

Topics

Choosing Between Antithrombotic Strategies for Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

20:00 EDT 18 Oct 2016 | NEJM

Bivalirudin does not reduce major cardiovascular events compared with heparin with or without glycoprotein IIb/IIIa inhibitors.

Original Article: Choosing Between Antithrombotic Strategies for Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

NEXT ARTICLE

More From BioPortfolio on "Choosing Between Antithrombotic Strategies for Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention"

Quick Search
Advertisement
 

Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...